Research ArticleCANCER IMMUNOLOGY

Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non–small cell lung cancer

See allHide authors and affiliations

Science Immunology  31 Jan 2020:
Vol. 5, Issue 43, eaav3937
DOI: 10.1126/sciimmunol.aav3937

Article Information

vol. 5 no. 43

PubMed: 
Published By: 
History: 
  • Received September 12, 2018
  • Revision received October 9, 2019
  • Accepted December 20, 2019
  • .

Author Information

  1. Eri Sugiyama1,2,*,
  2. Yosuke Togashi2,*,
  3. Yoshiko Takeuchi2,
  4. Sayoko Shinya2,
  5. Yasuko Tada2,
  6. Keisuke Kataoka3,
  7. Kenta Tane4,
  8. Eiichi Sato5,
  9. Genichiro Ishii6,
  10. Koichi Goto7,
  11. Yasushi Shintani8,
  12. Meinoshin Okumura8,
  13. Masahiro Tsuboi4 and
  14. Hiroyoshi Nishikawa1,2,
  1. 1Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  2. 2Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Chiba 277-8577, Japan.
  3. 3Division of Molecular Oncology, Research Institute, National Cancer Center, Tokyo 104-0045, Japan.
  4. 4Division of Thoracic Surgery,
  5. 5Department of Pathology, Institute of Medical Science, Tokyo Medical University, Tokyo 160-0023, Japan.
  6. 6Division of Pathology,
  7. 7Division of Thoracic Oncology, National Cancer Center Hospital East, Chiba 277-8577, Japan.
  8. 8Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  1. Corresponding author. Email: hnishika{at}ncc.go.jp
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: January 2020 to November 2020

AbstractFullPdf
Jan 20201443640
Feb 2020113897522151
Mar 2020697131101
Apr 20204176057
May 20204236037
Jun 20203786643
Jul 20203493843
Aug 20202865548
Sep 20203877239
Oct 202010919743
Nov 20203643720

Stay Connected to Science Immunology